James Cassidy
Chief Tech/Sci/R&D Officer bei SPRINGWORKS THERAPEUTICS, INC.
Vermögen: 1 Mio $ am 31.03.2024
Profil
James Cassidy is currently the Chief Medical Officer at Springworks Therapeutics, Inc. He previously held positions as the Global Head-Translational Research for Oncology at Hoffmann-La Roche, Inc., Professor-Oncology at the University of Glasgow from 2002 to 2011, Vice President-Translational Development at Celgene LLC from 2016 to 2020, Vice President-Oncology at Bristol Myers Squibb Co. from 2013 to 2016, and VP-Oncology Strategic Program Direction at Regeneron Pharmaceuticals, Inc. from 2020 to 2021.
He obtained his doctorate degree from the University of Glasgow in 1981.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 25.03.2024 | 23 749 ( 0,03% ) | 1 Mio $ | 31.03.2024 |
Aktive Positionen von James Cassidy
| Unternehmen | Position | Beginn |
|---|---|---|
| SPRINGWORKS THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01.08.2021 |
Ehemalige bekannte Positionen von James Cassidy
| Unternehmen | Position | Ende |
|---|---|---|
| REGENERON PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.08.2021 |
| Celgene LLC | Corporate Officer/Principal | 01.01.2020 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01.10.2016 |
| University of Glasgow | Corporate Officer/Principal | 01.01.2011 |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Corporate Officer/Principal | - |
Ausbildung von James Cassidy
| University of Glasgow | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| REGENERON PHARMACEUTICALS, INC. | Health Technology |
| SPRINGWORKS THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Health Technology |
| Celgene LLC |
